Rebecca J. Troisi | |
|---|---|
 | |
| Alma mater | Harvard T.H. Chan School of Public Health |
| Scientific career | |
| Fields | Cancer epidemiology |
| Institutions | National Cancer Institute |
Rebecca J. Troisi is an American cancer epidemiologist specialized in the hormonal etiologies of reproductive cancers. She is a staff scientist in the trans-divisional research program at the National Cancer Institute.
Troisi completed a Sc.D. from the Harvard T.H. Chan School of Public Health in 1994. [1] Her dissertation was titled, Epidemiology of adult-onset asthma. [2] She joined the National Cancer Institute (NCI) the same year. [1] Her research has focused on the hormonal etiologies of reproductive cancers and the role of maternal, gestational, neonatal and early life factors in breast cancer risk, including endocrine disruptors such as diethylstilbestrol, a drug previously given to pregnant women. [1] Troisi and colleagues Marlene Goldman and Kathryn Rexrode edited the second edition of Women and Health, a comprehensive review of the behavioral, social, and biological determinants of health and well-being in women, published in late 2012 by Elsevier. [1] Troisi is a staff scientist in the trans-divisional research program in the NCI division of cancer epidemiology and genetics. [1]
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
The Black Women's Health Study (BWHS) is a long-term observational study conducted at Boston University's Slone Epidemiology Center since 1995 to investigate the health problems of Black women over a long time period, with the ultimate goal of improving their health. Gaining information about the causes of health problems that affect Black women will help to determine health outcomes. The study, funded by the National Institutes of Health follows a cohort of the 59,000 women that enrolled.
Gretchen L. Gierach is an American epidemiologist and women's health researcher. She is the chief of the Integrative Tumor Epidemiology Branch in the National Cancer Institute.
Louise A. Brinton is an American epidemiologist. She was a senior investigator, Chief of the Hormonal and Reproductive Epidemiology Branch, and the first Scientific Advisor for International Activities of the National Cancer Institute Division of Cancer Epidemiology and Genetics.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Debra Toby Silverman is an American biostatistician and epidemiologist specialized in bladder cancer epidemiology and the carcinogenicity of diesel exhaust. Silverman is the chief of the occupational and environmental epidemiology branch at the National Cancer Institute.
Shelia Hoar Zahm is an American cancer epidemiologist specialized in pesticides and cancer, the etiology of non-Hodgkin lymphoma, and occupational cancer among women. She was deputy director of the National Cancer Institute's division of cancer epidemiology and genetics from 1998 to 2011.
Patricia A. Hartge is an American cancer epidemiologist who conducted genome-wide association studies on ovarian cancer, non-Hodgkin lymphoma, melanoma, and other malignancies. From 1996 to 2013, Hartge was deputy director of the epidemiology and biostatistics program in the division of cancer epidemiology and genetics at the National Cancer Institute.
Hannah P. Yang is an American cancer epidemiologist who is a staff scientist and associate director of scientific operations in the National Cancer Institute's division of cancer epidemiology and genetics.
Jill Suzanne Barnholtz-Sloan is an American biostatistician and data scientist specialized in cancer epidemiology and etiologic investigations of brain tumors. She is a senior investigator and associate director for informatics and data science at the National Cancer Institute.
Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Margaret Anne Tucker is an American oncologist and physician-scientist specialized in environmental and genetic epidemiology, familial cancers, and melanomas. She is a scientist emeritia at the National Cancer Institute (NCI). Tucker was a commissioned officer in the United States Public Health Service Commissioned Corps and served as director of the NCI human genetics program from 2005 until her retirement in June 2018.
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
Susan Shaw Devesa is an American cancer epidemiologist who conducts descriptive research of the patterns of cancer in the United States. She was a section chief of descriptive studies at the National Cancer Institute.
Aimée Rebecca Kreimer is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.
Regina Gale Ziegler is an American biochemist and nutritional epidemiologist who researched dietary, nutritional, anthropometric, and hormonal determinants of cancer risk. She was a senior investigator in the National Cancer Institute's epidemiology and biostatistics program.
Nan Hu is a Chinese physician-scientist, molecular geneticist, and cancer epidemiologist who researches gastrointestinal cancers. She is a staff scientist in the metabolic epidemiology branch at the National Cancer Institute.
Wen-Yi Huang is a cancer epidemiologist who primarily researches colorectal and prostate tumors. She is a staff scientist in the metabolic epidemiology branch at the National Cancer Institute.
Kathy J. Helzlsouer is an American oncologist, internist, and cancer epidemiologist who investigates cancer etiology and prevention, women's health, genetic counseling, and translational research. At the National Cancer Institute, she is the associate director of the epidemiology and genomics research program and chief medical officer for the division of cancer control and population sciences.
Susan Hankinson is an American cancer researcher who is the Distinguished Professor of Epidemiology at the University of Massachusetts Amherst. Her research considers cancer epidemiology and the etiology of breast cancer. Her work has demonstrated the relationship between hormones and breast cancer risk. In 2023, she was awarded the American Association for Cancer Research Award for Research Excellence in Cancer Epidemiology and Prevention.
This article incorporates text from this source, which is in the public domain . This article incorporates public domain material from websites or documents of the National Institutes of Health.